Pharmacogenetics of follicle-stimulating hormone action

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 3, 2012, Pages 220-227

  Laan, Maris ^a   Grigorova, Marina ^a   Huhtaniemi, Ilpo T ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

follicle stimulating hormone; follicle stimulating hormone beta subunit 211G T single nucleotide polymorphism; follicle stimulating hormone receptor Thr307Ala Asn680Ser; follicle stimulating hormone receptor 29G A single nucleotide polymorphism; pharmacogenetics

Indexed keywords

ALANINE; ASPARAGINE; FOLLITROPIN; FOLLITROPIN BETA SUBUNIT; FOLLITROPIN RECEPTOR; GONADORELIN; INHIBIN B; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; SERINE; TESTOSTERONE; THREONINE;

ALLELE; FERTILIZATION IN VITRO; GENE EXPRESSION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HORMONE ACTION; HUMAN; MALE INFERTILITY; OLIGOSPERMIA; OPTIMAL DRUG DOSE; OSTEOPOROSIS; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PHARMACOGENETICS; PREDICTIVE VALUE; PREMATURE OVARIAN FAILURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT PLANNING; TREATMENT RESPONSE;

FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; HUMANS; MALE; OVARIAN HYPERSTIMULATION SYNDROME; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PROMOTER REGIONS, GENETIC; RECEPTORS, FSH;

EID: 84860766272     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283534b11     Document Type: Review

References (73)

1. Weinbauer GF, Luetjens CM, Simoni M, Nieschlag E. Physiology of testicular function. 3rd ed. In Nieschlag E, Behre HM, Nieschlag S, editors. Andrology: male reproductive health and dysfunction. Berlin Heidelberg: Springer; 2010. pp. 11-61.
2. Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocr Rev 2009; 30:624-712.
3. Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 1997; 15:201-204. (Pubitemid 27061644)
4. Huhtaniemi I. Mutations along the pituitary-gonadal axis affecting sexual maturation: novel information from transgenic and knockout mice. Mol Cell Endocrinol 2006; 254-255:84-90. (Pubitemid 44041751)
5. Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell 2006; 125:247-260.
6. Allan CM, Kalak R, Dunstan CR, et al. Follicle-stimulating hormone increases bone mass in female mice. Proc Natl Acad Sci U S A 2010; 107:22629-22634.
7. Radu A, Pichon C, Camparo P, et al. Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Eng J Med 2010; 363: 1621-1630.
8. Bliss SP, Navratil AM, Xie J, Roberson MS. GnRH signaling, the gonadotrope and endocrine control of fertility. Front Neuroendocrinol 2010; 31:322-340.
9. O'Shaughnessy PJ, Fowler PA. Endocrinology of the mammalian fetal testis. Reproduction 2011; 141:37-46.
10. Ruwanpura SM, McLachlan RI, Meachem SJ. Hormonal regulation of male germ cell development. J Endocrinol 2010; 205:117-131.
11. Nieschlag E, Simoni M, Gromoll J, Weinbauer GF. Role of FSH in the regulation of spermatogenesis: clinical aspects. Clin Endocrinol (Oxf) 1999; 51:139-146. (Pubitemid 29378894)
12. Plant TM, Marshall GR. The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr Rev 2001; 22:764-786. (Pubitemid 34214294)
13. McNeilly AS, Crawford JL, Taragnat C, et al. The differential secretion of FSH and LH: regulation through genes, feedback and packaging. Reprod Suppl 2003; 61:463-476.
14. Corless CL, Bielinska M, Ramabhadran TV, et al. Gonadotropin alpha subunit. Differential processing of free and combined forms in human trophoblast and transfected mouse cells. J Biol Chem 1987; 262:14197-14203. (Pubitemid 17152099)
15. Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 1997; 18:739-773. (Pubitemid 28009566)
16. Nagirnaja L, Rull K, Uusküla L, et al. Genomics and genetics of gonadotropin beta-subunit genes: unique FSHB and duplicated LHB/CGB loci. Mol Cell Endocrinol 2010; 329:4-16.
17. Grigorova M, Rull K, Laan M. Haplotype structure of FSHB, the beta-subunit gene for fertility-associated follicle-stimulating hormone: possible influence of balancing selection. Ann Hum Genet 2007; 71:18-28. (Pubitemid 44857679)
18. Grigorova M, Punab M, Ausmees K, Laan M. FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men. Hum Reprod 2008; 23:2160-2166.
19. Grigorova M, Punab M, Poolamets O, et al. Increased Prevalance of the 211 T allele of follicle stimulating hormone (FSH) beta subunit promoter polymorphism and lower serum FSH in infertile men. J Clin Endocrinol Metab 2010; 95:100-108.
20. Grigorova M, Punab M, Zilaitien,et al. Genetically determined dosage of follicle-stimulating hormone (FSH) affects male reproductive parameters. J Clin Endocrinol Metab 2011; 96:E1534-E1541.
21. Ferlin A, Vinanzi C, Selice R, et al. Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter. Fertil Steril 2011; 96:1344-1349e2.
22. Tüttelmann F, Terwort N, Laan M, Gromoll J. FSHB promotor polymorphism influences male reproductive parameters. J Reproduktionsmed Endokrinol 2011; 8:305-345.
23. Tong Y, Liao WX, Roy AC, Ng SC. Association of AccI polymorphism in the follicle-stimulating hormone beta gene with polycystic ovary syndrome. Fertil Steril 2000; 74:1233-1236.
24. He C, Kraft P, Chasman DI, et al. A large-scale candidate gene association study of age at menarche and age at natural menopause. Hum Genet 2010; 128:515-527.
25. La Marca A, Carducci Artenisio A, Stabile G, et al. Evidence for cycledependent expression of follicle-stimulating hormone receptor in human endometrium. Gynecol Endocrinol 2005; 21:303-306. (Pubitemid 43068026)
26. Lalioti MD. Impact of follicle stimulating hormone receptor variants in fertility. Curr Opin Obstet Gynecol 2011; 23:158-167.
27. Gromoll J, Simoni M, Nieschlag E. An activating mutation of the follicle stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab 1996; 81:1367-1370. (Pubitemid 26118564)
28. Allan CM, Garcia A, Spaliviero J, et al. Maintenance of spermatogenesis by the activated human (Asp567Gly) FSH receptor during testicular regression due to hormonal withdrawal. Biol Reprod 2006; 74:938-944.
29. Allan CM, Lim P, Robson M, et al. Transgenic mutant D567G but not wild-type human FSH receptor overexpression provides FSH-independent and promiscuous glycoprotein hormone Sertoli cell signaling. Am J Physiol Endocrinol Metab 2009; 296:E1022-E1028.
30. Peltoketo H, Strauss L, Karjalainen R, et al. Female mice expressing constitutively active mutants of FSH receptor present with a phenotype of premature follicle depletion and estrogen excess. Endocrinology 2010; 151:1872-1883.
31. Simoni M, Gromoll J, Höppner W, et al. Mutational analysis of the folliclestimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 1999; 84:751-755. (Pubitemid 29075716)
32. Perez Mayorga M, Gromoll J, Behre HM, et al. Ovarian response to folliclestimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000; 85:3365-3369.
33. Behre HM, Greb RR, Mempel A, et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 2005; 15:451-456. (Pubitemid 41017593)
34. Casarini L, Pignatti E, Simoni M. Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function. Rev Endocr Metab Disord 2011; 12:303-321.
35. Altmäe S, Hovatta O, Stavreus-Evers A, Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update 2011 17 813-828.
36. Yao Y, Ma CH, Tang HL, Hu YF. Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis. Mol Genet Metab 2011; 103:388-393.
37. Greb RR, Grieshaber K, Gromoll J, et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 2005; 90:4866-7482.
38. Wang HS, Cheng BH, Wu HM, et al. A mutant single nucleotide polymorphism of follicle-stimulating hormone receptor is associated with a lower risk of endometriosis. Fertil Steril 2011; 95:455-457.
39. Corbo RM, Gambina G, Broggio E, Scacchi R. Influence of variation in the follicle-stimulating hormone receptor gene (FSHR) and age at menopause on the development of Alzheimer's disease in women. Dement Geriatr Cogn Disord 2011; 32:63-69.
40. Ferlin A, Pengo M, Selice R, et al. Analysis of single nucleotide polymorphisms of FSH receptor gene suggests association with testicular cancer susceptibility. Endocr Relat Cancer 2008; 15:429-437. (Pubitemid 351880832)
41. Yang CQ, Chan KY, Ngan HY, et al. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility. Carcinogenesis 2006; 27:1502-1506. (Pubitemid 43985424)
42. Heubner M, Riemann K, Otterbach F, et al. The haplotype of two FSHR polymorphisms in ovarian cancer-a potential role of ethnology in risk modification. Gynecol Oncol 2009; 112:486-489.
43. Ludwig AH, Murawska M, Panek G, et al. Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome. Endocr Relat Cancer 2009; 16:1005-1016.
44. Nakayama T, Kuroi N, Sano M, et al. Mutation of the follicle-stimulating hormone receptor gene 50-untranslated region associated with female hypertension. Hypertension 2006; 48:512-518. (Pubitemid 44253748)
45. Desai SS, Achrekar SK, Pathak BR, et al. Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in Granulosa cells. J Clin Endocrinol Metab 2011; 96:2805-2812.
46. Achrekar SK, Modi DN, Meherji PK, et al. Follicle stimulating hormone receptor gene variants in women with primary and secondary amenorrhea. J Assist Reprod Genet 2010; 27:317-326.
47. Lend AK, Belousova A, Haller-Kikkatalo K, et al. Follicle-stimulating hormone receptor gene haplotypes and male infertility in Estonian population and metaanalysis. Syst Biol Reprod Med 2010; 56:84-90.
48. Kerns SL, Ostrer H, Stock R, et al. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010; 78:1292-1300.
49. Plunkett J, Doniger S, Orabona G, et al. An evolutionary genomic approach to identify genes involved in human birth timing. PLoS Genet 2011; 7: e1001365.
50. Sikaris K,McLachlan RI, Kazlauskas R, et al. Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metab 2005; 90:5928-5936. (Pubitemid 41606507)
51. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011; 7:219-231.
52. Petr?́ková J, Lazúrová I. Ovarian failure and polycystic ovary syndrome. Autoimmun Rev 2012. doi:10.1016/j.autrev.2011.11.010.
53. Kahsar-Miller M, Azziz R. The development of the polycystic ovary syndrome: family history as a risk factor. Trends Endocrinol Metab 1998; 9:55-58. (Pubitemid 28207613)
54. Valkenburg O, Uitterlinden AG, Piersma D, et al. Genetic polymorphisms of GnRH and gonadotropin hormone receptors affect the phenotype of polycystic ovary syndrome. Hum Reprod 2009; 24:2014-2022.
55. Chen ZJ, Zhao H, He L, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33. Nat Genet 2011; 43:55-59.
56. Zhao H, Xu X, Xing X, et al. Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16. 3, 2p21 and 9q33. 3. Hum Reprod 2012; 27:294-298.
57. Du J, Zhang W, Guo L, et al. Two FSHR variants, haplotypes and metaanalysis in Chinese women with premature ovarian failure and polycystic ovary syndrome. Mol Genet Metab 2010; 100:292-295.
58. Overbeek A, Kuijper EA, Hendriks ML, et al. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum Reprod 2009; 24:2007-2013.
59. Burgers JA, Fong SL, Louwers YV, et al. Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference? J Clin Endocrinol Metab 2010 95 E485-E489.
60. Dolfin E, Guani B, Lussiana C, et al. FSH-receptor Ala307Thr polymorphism is associated to polycystic ovary syndrome and to a higher responsiveness to exogenous FSH in Italian women. J Assist Reprod Genet 2011; 28:925-930.
61. Shelling AN. Premature ovarian failure. Reproduction 2010; 140:633-641.
62. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009; 360:606-614.
63. Kim S, Pyun JA, Cha DH, et al. Epistasis between FSHR and CYP19A1 polymorphisms is associated with premature ovarian failure. Fertil Steril 2011; 95:2585-2588.
64. Rendina D, Gianfrancesco F, De Filippo G, et al. FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women. Eur J Endocrinol 2010; 163:165-172.
65. Morón FJ, Ruiz A. Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers. Pharmacogenomics 2010; 11:1613-1618.
66. Daelemans C, Smits G, de Maertelaer V, et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by folliclestimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab 2004; 89:6310-6315. (Pubitemid 39628451)
67. Achrekar SK, Modi DN, Desai SK, et al. Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism. Reprod Biomed Online 2009; 18:509-515.
68. Gerasimova T, Thanasoula MN, Zattas D, et al. Identification and in vitro characterization of follicle stimulating hormone (FSH) receptor variants associated with abnormal ovarian response to FSH. J Clin Endocrinol Metab 2010; 95:529-536.
69. Foresta C, Selice R, Ferlin A, et al. Hormonal treatment of male infertility: FSH. Reprod Biomed Online 2007; 15:666-672. (Pubitemid 350285981)
70. Foresta C, Selice R, Garolla A, Ferlin A. Follicle-stimulating hormone treatment of male infertility. Curr Opin Urol 2008; 18:602-607.
71. Selice R, Garolla A, Pengo M, et al. The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms. Int J Androl 2011; 34:306-312.
72. Bouvattier C, Maione L, Bouligand J, et al. Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism. Nat Rev Endocrinol 2011; 8:172-182.
73. Raivio T, Wikström AM, Dunkel L. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome. Eur J Endocrinol 2007; 156:105-111. (Pubitemid 46553909)